UK Markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
16.30-0.71 (-4.16%)
At close: 07:09PM GMT
Full screen
Previous close17.01
Bid0.00 x 0
Ask0.00 x 0
Day's range16.23 - 17.50
52-week range16.23 - 17.50
Avg. volumeN/A
Market cap1.488B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-3.88
Earnings date04 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    What Especially Stood Out From Invitae's Q3 Results

    Invitae (NYSE: NVTA) announced its third-quarter results on Nov. 8, 2021. In this Motley Fool Live video recorded on Nov. 10, Motley Fool contributors Keith Speights and Brian Orelli discuss what especially stood out in the company's Q3 update. Ticker there is NVTA.

  • Motley Fool

    3 Beaten-Down Genomics Stocks: Can They Recover?

    All three of these companies can test for COVID-19, but they're well-suited to produce steadier revenue in ways that have nothing to do with coronaviruses. Exact Sciences' (NASDAQ: EXAS) stock price has tumbled around 41% since its high watermark this February. Screening for cancer is this company's bread and butter, but rapidly rising COVID-19 testing revenue excited investors enough to drive the stock to new all-time highs earlier this year.

  • Motley Fool

    3 Stocks That Could Soar 46% or More, According to Wall Street

    Are you looking for undervalued stocks to buy? If so analysts on Wall Street think there are at least a few stocks in the healthcare sector that deserve more attention than they've been getting lately. Telehealth, vaccines, and genetic testing could make these stocks huge winners down the road.